Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes

Quality of Life Clinical Trial

— RECENPE  

Official title:

Residències Centrades en Les Persones (RECENPE): avaluació de l'Impacte d'un Model d'ACP en residències Per Persones Grans

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03200145
• Other study ID #: FSIE1704
• Secondary ID: CEEAH - 3786
• Status: Not yet recruiting
• Phase: N/A
• First received: June 20, 2017
• Last updated: June 26, 2017
• Start date: June 27, 2017
• Est. completion date: February 2018

Study information

• Verified date: June 2017
• Source: Fundacio Salut i Envelliment UAB
• Contact: Xavier Rojano Luque, MD
• Phone: 93 433 50 53
• Email: xavier.rojano[@]uab.cat
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Cohort Observational Study. The study will assess differences in quality of life, well-being and mood between persons living in a nursing home following usual care and persons living in nursing homes following a centered person care model.

Initially, the follow up will last 6 months, with the possibility to be extended.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 170
• Est. completion date: February 2018
• Est. primary completion date: February 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Persons living in nursing homes

• Consent from the person (or legal representative, if the person is not able)

Exclusion Criteria:

• Terminal illness

• Living temporary in a nursing home

Related Conditions & MeSH terms

• Health Services for the Aged
• Mood
• Quality of Life

Intervention

Other:
• ACP intervention
The intervention group made by persons living in nursing homes using a person centered attention model relying on two dimensions: - Attention to the person based on: Knowledge of the person in several dimensions (biological, psychological, social, etc), interests and preferences. Respect and acknowledge of the person. Promotion of the autonomy. Personalized treatment, with tailored attention and integrative cures Protection of physical well-being, preventing damages and risks and promoting healthy habits. Promotion of independence on daily activities. Protection of privacy and personal matters - Positive environment based on: Physical space, including accessibility, comfort, homely environment, with stimulating spaces for physical activity, social relationships and significant activities for the persons. Social relationships, with proximity and collaboration with families. Friendly organization, with empathetic professionals empowering users.

Locations

Country	Name	City	State
Spain	Residència i Centre de dia Sant Hilari	Sant Hilari Sacalm	Girona
Spain	Residència "Casa del Avis"	Sant Sadurní d'Anoia	Barcelona

Sponsors (2)

Lead Sponsor	Collaborator
Fundacio Salut i Envelliment UAB	SUMAR empresa d'acció social de Catalunya

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Thriving in nursing homes	Thriving in nursing homes will be assessed with the Thriving of Older People Assessment Scale (TOPAS).; Investigators will assess the change between groups.	0, 6 months
Primary	Quality of life	Quality of life will be assessed with the Euroqol 5D-5L. Investigators will assess the change between groups.	0, 6 months
Primary	Well-being	Well-being will be assessed by the WHO (Five) Well Being Index (1998 version). Investigators will assess the change between groups.	0, 6 months
Secondary	Depressive symptoms	Cognitive impairment affects the assessment of depressive symptoms. For this reason, according to their stage using the Reisberg Global Deterioration Scale, investigators will assess the presence or absence of depressive symptoms with two tools; stage 0 to 4: investigators will consider that a person has depressive symptoms with a score of 6 or more using the 15 items Yesavage Geriatric Depression Scale,; stage 5 to 7: investigators will consider that a person has depressive symptoms with a score of 11 or more using the Cornell Depression Scale.; Investigators will assess the change in the prevalence of depressive symptoms between groups.	0, 6 months
Secondary	Neuropsychiatric inventory	Neuropsychiatric symptoms will be assessed with the Brief Neuropsychiatric inventory(NPI-Q). Investigators will assess the change between groups.	0,6 months